Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-025099
Filing Date
2022-11-14
Accepted
2022-11-14 17:27:34
Documents
69
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aclx-20220930.htm   iXBRL 10-Q 3420821
2 EX-10.1 aclx-ex10_1.htm EX-10.1 243753
3 EX-31.1 aclx-ex31_1.htm EX-31.1 15665
4 EX-31.2 aclx-ex31_2.htm EX-31.2 15660
5 EX-32.1 aclx-ex32_1.htm EX-32.1 9809
6 EX-32.2 aclx-ex32_2.htm EX-32.2 10110
  Complete submission text file 0000950170-22-025099.txt   9521115

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aclx-20220930_pre.xml EX-101.PRE 316326
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aclx-20220930_def.xml EX-101.DEF 208994
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aclx-20220930.xsd EX-101.SCH 46773
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aclx-20220930_lab.xml EX-101.LAB 406861
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aclx-20220930_cal.xml EX-101.CAL 58216
63 EXTRACTED XBRL INSTANCE DOCUMENT aclx-20220930_htm.xml XML 1403299
Mailing Address 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD 20878
Business Address 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD 20878 240-723-6641
Arcellx, Inc. (Filer) CIK: 0001786205 (see all company filings)

EIN.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41259 | Film No.: 221388009
SIC: 2836 Biological Products, (No Diagnostic Substances)